DTC For Accelerated Approval Drugs: US FDA Is Taking Another Look At Disclosure On Websites

Study will assess responses of cancer survivors and caregivers to disclosures that a drug received accelerated approval. FDA analysis found that 73% of 26 accelerated approval drugs cited approval pathway on product websites.